Table I.
Variables related to demographic characteristics and prior history of patients.
| Entire study sample (n = 238) | COVID-19 related- headache (n = 143) | COVID-19 vaccine related-headache (n = 95) | FDR-corrected p-value | |
|---|---|---|---|---|
| Median age, (SD) | 35.5 (10.6) | 36.2 (8.6) | 30 (13) | 0.438 |
|
| ||||
| Female sex, n (%) | 180 (75.6%) | 105 (73.4%) | 75 (78.9%) | 0.478 |
|
| ||||
| Prior history of headache, n (%) | 32 (13.4%) | 20 (14%) | 12 (12.6%) | 0.903 |
|
| ||||
| Family history of headache, n (%) | 78 (32.8%) | 33 (23.15) | 45 (47.4%) | <0.001 |
|
| ||||
| Family history of migraine, n (%) | 67 (28.2%) | 33 (23.1%) | 34 (35.8%) | 0.214 |
|
| ||||
| Hypertension, n (%) | 7 (2.9%) | 2 (1.4%) | 5 (5.3%) | 0.387 |
|
| ||||
| Diabetes. n (%) | 7 (2.9%) | 2 (1.4%) | 5 (5.3%) | 0.309 |
|
| ||||
| Smoking, n (%) | 27 (11.3%) | 19 (11.3%) | 8 (8.4%) | 0.557 |
|
| ||||
| Cardiological disorders, n (%) | 7 (2.9%) | 4 (2.8%) | 3 (3.2%) | 0.999 |
|
| ||||
| Pulmonary disorders, n (%) | 9 (3.8%) | 7 (4.9%) | 2 (2.1%) | 0.525 |
|
| ||||
| Oncological disorders, n (%) | 6 (2.5%) | 3 (2.1%) | 3 (3.2%) | 0.89 |
|
| ||||
| Neurological disorders, n (%) | 9 (3.8%) | 5 (3.5%) | 4 (4.2%) | 0.999 |
|
| ||||
| Immunosuppression, n (%) | 3 (1.3%) | 0 (0%) | 3 (3.2%) | 0.287 |
FDR: false discovery rate; SD: standard deviation.